BPC-157
Body Protection Compound · Bepecin · PL 14736
The gut-healing, tendon-repairing peptide that started the biohacking revolution.
What is BPC-157?
If there's one peptide that put biohacking on the map, it's BPC-157. Originally isolated from human gastric juice (yes, your stomach makes this stuff), it's been studied extensively for its ability to accelerate healing in tendons, ligaments, muscles, and the gut lining. The research community has been quietly obsessed with it for decades, and now the broader health world has caught on.
Here's what makes BPC-157 interesting: it doesn't just mask problems. The research suggests it actually promotes angiogenesis (new blood vessel formation) at injury sites, which is how your body naturally repairs damage. It's like turning up the volume on your own healing system.
How Does It Work?
BPC-157 works through multiple pathways simultaneously — which is unusual for a single peptide. It upregulates growth factor expression (particularly VEGF and EGF), modulates the nitric oxide system, and interacts with the dopamine and serotonin systems. This multi-pathway action is why researchers see effects across so many different tissue types.
The gut connection is particularly fascinating. Since BPC-157 is naturally found in gastric juice, it has a natural affinity for the GI tract. Research shows it can protect against NSAID-induced gut damage, alcohol-induced lesions, and inflammatory bowel conditions — at least in animal models.
What Does The Research Say?
Moderate evidence. Some human data, mostly animal studies.
The elephant in the room: most BPC-157 research is in animals, not humans. There are over 100 published studies, but the vast majority are in rats and mice. The results are consistently impressive — accelerated tendon healing, reduced inflammation, neuroprotective effects, gut protection — but we're still waiting for large-scale human clinical trials.
That said, a Phase II human trial for inflammatory bowel disease was initiated (PL 14736), which gives some legitimacy to the research direction. The anecdotal human reports from the biohacking community are overwhelmingly positive, particularly for tendon injuries and gut issues, but anecdotes aren't evidence.
Reported Dosages
These are dosages reported in research literature and community reports. They are NOT medical recommendations. Always consult a healthcare professional.
Research literature typically uses 1-10 mcg/kg body weight in animal studies. The biohacking community commonly reports using 250-500 mcg per day, either subcutaneously near the injury site or orally for gut-related issues. Some protocols use twice-daily dosing.
Important: These are reported research dosages, not medical recommendations. There are no officially approved human dosages because BPC-157 is not an approved medication.
Side Effects & Risks
Animal studies report minimal side effects, which is part of what makes BPC-157 unusual among peptides. The most commonly reported side effects in anecdotal human use are mild nausea (especially with oral use) and occasional dizziness. Some researchers have raised theoretical concerns about BPC-157's ability to promote blood vessel growth potentially affecting tumour progression, though this hasn't been demonstrated in studies.
Legal Status by Country
Not approved for human use. Available as a research chemical. Not controlled.
Not FDA-approved. Available as a research chemical. Recently proposed for scheduling by FDA.
Not approved. Available as research chemical in most EU countries.
Prescription only as of 2023 (TGA Schedule 4).
Important Disclaimer
This profile is for educational and research purposes only. It does not constitute medical advice. BPC-157 may be regulated or illegal in your jurisdiction. Do not use any compound without consulting a qualified healthcare professional. StackPedia does not sell, supply, or promote the use of any controlled substance.